SumiSaujana Group Sdn. Bhd. – Trademark Portfolio
Entity Type: 24
SumiSaujana Group Sdn. Bhd. holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 2 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 3 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include S and SUMISAUJANA.
Unit 30-01, Level 30, Tower A,
Vertical Business Suite, Avenue 3, Bangsar South, No. 8, Jalan Kerinchi, Wilayah Persekutuan Kuala Lumpur 59200
Showing of trademarks Trademarks
Trademark Classifications
SumiSaujana Group Sdn. Bhd.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does SumiSaujana Group Sdn. Bhd. have?
SumiSaujana Group Sdn. Bhd. has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.
What trademark classes does SumiSaujana Group Sdn. Bhd. file in?
SumiSaujana Group Sdn. Bhd. files trademarks across 3 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 42 (Computer & Scientific), Class 40 (Treatment & Processing). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.
What are SumiSaujana Group Sdn. Bhd.'s most well-known trademarks?
SumiSaujana Group Sdn. Bhd.'s registered trademark portfolio includes well-known marks such as S and SUMISAUJANA. These are among 2 currently registered trademarks in the portfolio.
What is SumiSaujana Group Sdn. Bhd.'s trademark registration success rate?
SumiSaujana Group Sdn. Bhd. has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.